Skip to main content
. 2013 Nov 15;27(22):2439–2444. doi: 10.1101/gad.227165.113

Figure 2.

Figure 2.

V(D)J joining can follow CSR in early B-cell lines. Cells were untreated (U) or activated with LPS+CD40L (LC) or LPS+CD40L+IL4 (LCI). Results are representative of three to nine samples from three independent experiments. (A) DC-PCR analysis of CSR in R2K2 and in clones A2 and B5. (B) STI571 treatment induces Rag1, Igκ GLT, and Irf4 expression as assessed by quantitative RT–PCR in B5 and A2 clones. (C) DDFL16 → JH1 CJs assessed in A2 and B5 clones transfected with empty (E) or Rag2 (R) expression constructs and the Mb1 loading control. (D, top) Treatment timeline in PA112.2 cells. (Bottom) Quantitative RT–PCR for AID and Rag2 expression. (E) Semiquantitative RT–PCR for PST γ2b and ɛ or Hprt. (F) Vκ6–23 → Jκ1 CJs and Mb1 assessed by semiquantitative PCR.